Oncology Business Management | Specialty

Treatment Approaches in Non-Driver Adenocarcinoma

July 19th 2016

ALK-Positive NSCLC

July 19th 2016

EGFR TKI Sequencing

July 19th 2016

Osimertinib for the T790M Resistance Mutation

July 19th 2016

TKIs for EGFR Del19 and Beyond Progression

July 19th 2016

Refining Use of EGFR TKIs, Adding Bevacizumab

July 19th 2016

Molecular Testing in Squamous Cell Tumors

July 19th 2016

The Emergence of Liquid Biopsy in Lung Cancer

July 19th 2016

The Importance of Comprehensive Genomic Profiling

July 19th 2016

Lung Cancer Molecular Testing

July 19th 2016

Threefold Growth in Cancer Center Ads

July 19th 2016

Television garners the most advertising dollars from cancer centers, but print and Internet media have seen threefold increases in cancer ads,

CMS: Oncology Care Model Will Be Tough But Worth It

July 19th 2016

Ron Kline, MD, explains that there are bound to be technical difficulties with an ambitious program such as the Oncology Care Model.

FDA Grants Nivolumab Priority Review for Head and Neck Cancer

July 18th 2016

The FDA has granted a priority review designation to nivolumab as a treatment for patients with previously treated metastatic or recurrent squamous cell carcinoma of the head and neck.

Rx for Protection Rather Than For Cure

July 17th 2016

Physicians tend to agree that the practice of defensive medicine is widespread, especially in oncology where much more is at stake than in the general practitioner's office. However, things can go drastically wrong.

Oncology Practice Vitality Depends on Leadership

July 16th 2016

The pace of consolidation shows no sign of slowing down, and this trend also applies to oncology, as more and more community-based oncology practices are joining large health systems.

FDA Grants LOXO-101 Breakthrough Designation for Solid Tumors

July 14th 2016

The FDA granted the selective tropomyosin receptor kinase inhibitor LOXO-101 a breakthrough therapy designation for the treatment of adult or pediatric patients with unresectable or metastatic solid tumors with NTRK-infusion proteins who progressed on prior therapy or have no other available treatment options.

New Hampshire Leads Independent Oncology Practice Decline

July 14th 2016

The statistics show you are much more likely to encounter an independent oncology practice in Alaska than in New Hampshire.

CMS Wavers on Commitment to MACRA Reforms

July 14th 2016

The Centers for Medicare & Medicaid Services is wavering on its commitment to the Medicare reform package passed in 2015, based on widespread concerns that the changes may be unwieldy and could increase the pace at which smaller physician practices are being forced into mergers.

Rural Oncology Practices Struggle to Recruit and Retain Employees

July 13th 2016

Pressures on independent oncology practices have been mounting for years, as payer data-reporting requirements become more onerous and revenue from drug reimbursements decline.

Rough Start for Oncology Care Model

July 12th 2016

Many oncology practices were motivated to join the Oncology Care Model in order to keep up with the evolution of value-based care. But when the Center for Medicare & Medicaid Innovation started telling practices that their applications had been accepted, it was panic time for some.